Texas A&M Football

Defense in Review feat. Sean Porter: Texas A&M 44, Utah State 22

Mike Elko's defense took a step forward on Saturday night as Texas A&M picked up a Week 2 victory over Utah State with a top-20 showdown looming ahead. Billy Liucci and Sean Porter break down the defensive showing from the Maroon & White in a 44-22 win at Kyle Field.
By Billy Liucci
September 9, 2025
1.1k Views
Discuss
Story Poster

• OK, I’m going to start with an individual performance, which is rare when penning the Defense in Review column, but this week has to start with defensive end Cashius Howell’s one-man show in the second quarter. With Utah State trying to come out of its own red zone, the senior took over the game in a manner I haven’t seen in more than 25 years of covering Aggie football.

To watch this video, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Mike Elko Sean Porter Dat Nguyen Von Miller Defense in Review Myles Garrett Tony Jerod-Eddie Marcus Freeman Mike Denbrock Bryson Barnes Jeremiyah Love Jadarian Price
Show All
Miles Davis Brady Boyd Texas A&M vs. Utah State Texas A&M at Notre Dame Albert Regis Bryce Anderson Julio Humphrey Tyreek Chappell Le'Veon Moss Sam M'Pemba Tyler Onyedim Dalton Brooks Marcel Reed KC Concepcion T.J. Searcy Taurean York Dezz Ricks Marcus Ratcliffe Landon Rink Marco Jones Will Lee III Scooby Williams Cashius Howell Dayon Hayes Football Texas A&M Notre Dame Utah State 2025
SPONSORED BY
Spec's
More Football
See All →
B-Team: Winners and losers in CFB, best smells in sports & more
By Ryan Brauninger
Ask Liucci: Touchdown Jesus looking down on Ags vs. Irish & more
By Billy Liucci
A&M's new-look receiving corps expect man-to-man coverage vs. Irish
By Olin Buchanan
Presenting Texas Aggies United’s Bad Tigers Sweepstakes!
By Texas Aggies United
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.